Parnax Lab Peer Comparison

BSE: 506128

₹118.42

₹-9.78 (-7.63%)

As on 21-Sep-2026IST

Market cap

₹137 Cr

Revenue (TTM)

₹252 Cr

P/E Ratio

15.3

P/B Ratio

1.4

Div. Yield

0 %

Edit

	Parnax Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Market cap (₹ Cr)	137	20,956	20,944	17,950	18,477
Revenue (₹ Cr)	252	2,287	1,682	3,230	2,570
Net Profit (₹ Cr)	8.95	678.07	273.51	666.92	735.15
Net Margin (%)	3.50	28.10	16.19	20.60	26.88
RoE (%)	10.86	19.73	11.15	18.75	19.16
Price to Earnings	15.32	31.50	70.44	27.88	25.13
Price-To-Book	1.43	5.71	7.80	4.45	4.19

Income Statement (₹ Cr)

	Parnax Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Operating Revenue	251.97	2,287.33	1,682.47	3,229.67	2,569.77
Total Income	255.72	2,413.29	1,689.83	3,237.12	2,735.39
Total Expenditure	227.85	1,490.75	1,203.91	2,090.06	1,628.14
EBITDA	24.12	796.58	478.55	1,139.61	941.63
Depreciation	8.33	78.10	126.01	281.06	57.58
EBIT	15.79	718.48	352.55	858.55	884.05
Interest	6.13	0.88	52.11	190.64	7.69
Other Income	3.75	125.96	7.37	7.45	165.62
Exceptional Items	-1.37	0.00	12.16	-17.24	-49.16
Profit before Tax	12.05	843.56	319.96	658.12	992.82
Provision for Tax	3.10	165.49	46.45	-8.80	257.67
Profit after Tax	8.95	678.07	273.51	666.92	735.15

	Parnax Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Shareholder's Funds	95.14	3,586.42	2,591.20	3,902.67	4,202.90
Minority Interest	-0.01	-12.71	0.00	-21.81	0.00
Non-Current Liabilities	36.48	28.74	266.35	1,392.75	91.50
Current Liabilities	95.85	385.94	848.06	2,077.10	627.48
Total Liabilities	189.82	3,207.85	3,310.68	6,865.52	4,911.11

	Parnax Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Non-Current Assets	118.89	1,291.22	2,525.44	5,617.77	770.28
Current Assets	93.04	2,585.66	1,109.77	1,539.85	3,803.22
Total Assets	189.82	3,207.85	3,310.68	6,865.52	4,911.11
Total Debt*	60.64	0.55	586.37	2,421.66	2.50
Net Current Assets	-2.81	2,199.72	261.71	-537.25	3,175.74
Contingent Liabilities	1.46	0.64	76.22	51.96	363.79

	Parnax Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Cash From Operating Activities	32.30	432.37	132.27	1,065.01	659.75
Cash Flow from Investing Activities	-16.39	-334.73	-199.13	-79.97	-71.34
Cash from Financing Activities	-15.82	-38.32	62.65	-881.32	-205.34
Net Cash Inflow / Outflow	0.09	59.32	-4.21	103.72	383.07

	Parnax Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
ROCE (%)	14.71	26.22	6.95	13.59	26.21
ROE (%)	10.86	19.73	11.15	18.75	19.16
ROA (%)	4.29	18.69	7.80	9.26	14.95
EBIT Margin (%)	6.27	31.41	20.95	26.58	34.40
Net Margin (%)	3.50	28.10	16.19	20.60	26.88
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Parnax Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Revenue Growth (%)	31.93	15.01	27.91	9.59	10.69
EBIT Growth (%)	-12.71	18.45	58.32	16.84	24.14
Net Profit Growth (%)	-17.36	19.61	149.56	62.68	-9.09
EPS Growth (%)	-7.00	17.73	-3.57	67.41	14.40
Book Value Growth (%)	16.10	23.77	30.63	10.19	17.30

	Parnax Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Price / Earnings	13.62	31.50	74.73	27.20	23.95
Price / Book Value	1.43	5.71	7.80	4.45	4.19
Dividend Yield (%)	0.00	0.29	0.06	0.00	1.86
EV/EBITDA	8.08	25.04	45.05	17.72	16.32
Market Cap (₹ Cr)	122.89	15,219.80	6,484.12	19,292.77	18,318.10

	Parnax Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Debt to Equity	0.23	0.00	0.07	0.24	0.00
Short term debt to equity ratio	0.43	0.00	0.13	0.14	0.00
Current Ratio	0.97	6.70	1.31	0.74	6.06
Quick Ratio	0.59	5.59	0.88	0.53	5.31
Interest Coverage	2.97	959.59	7.14	4.45	130.11

	Parnax Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Debtors to sales (%)	15.01	36.10	30.84	21.07	7.07
Asset Turnover	1.21	0.63	0.48	0.45	0.52
Receivable days	61.56	110.70	118.15	54.06	29.10
Inventory Days	54.14	65.86	98.29	32.16	69.53
Payable days	85.60	105.88	128.16	140.91	76.77
Cash Conversion Cycle	30.10	70.68	88.28	-54.69	21.86

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.